KAINOS MEDICINE, INC.
220250·Unlisted · delisted·6 grants
- Shares granted, cumulative
- 1,418,761shares
- Next lockup release
- —
- Lockup over — exercisable now
- 1,418,761shares6 of 6 grants · 100% of shares still inside their exercise window
Recipients by role
- Registered director1 person0%
- Unregistered officer4 people0%
- Employee32 people0%
- Other · unknown52 people100%
Sorted from the relation text written in the filings (89 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Cumulative grants per recipient
33 named · 25 withheld| Recipient | Shares, cumulative | Average strike | Exercisable |
|---|---|---|---|
| 100,00028.6% | ₩18,550 | 100,000 | |
| 50,00014.3% | ₩16,600 | 50,000 | |
| 50,00014.3% | ₩18,550 | 50,000 | |
| 30,0008.6% | ₩18,550 | 30,000 | |
| 25,0007.1% | ₩16,600 | 25,000 | |
| 15,0004.3% | ₩16,600 | 15,000 | |
| 10,0002.9% | ₩16,600 | 10,000 | |
| 00.0% | — | — | |
| 00.0% | — | — | |
| 00.0% | — | — |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20201 grant · 215,000 shares
- Granted2020-03-13
- Exercise starts2023-03-13
- Exercise ends2033-03-12
- Shares granted
- 215,000shares
- Strike price
- 18,550KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Report on grant of stock options
20192 grants · 332,500 shares
- Filed 2019-07-30 · grant details not collectedDART filing
DART does not serve the source document for this filing. Check the number of shares, the strike price and the lockup release date in the DART filing itself.
[Amended] Report on grant of stock options
- Granted2019-03-25
- Exercise starts2022-03-25
- Exercise ends2032-03-25
- Shares granted
- 332,500shares
- Strike price
- 16,600KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Report on grant of stock options
20181 grant · 246,500 shares
- Granted2018-03-26
- Exercise starts2020-03-26
- Exercise ends2030-03-25
- Shares granted
- 246,500shares
- Strike price
- 12,230KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Report on grant of stock options
20171 grant · 398,600 shares
- Granted2017-03-24
- Exercise starts2019-03-24
- Exercise ends2029-03-23
- Shares granted
- 398,600shares
- Strike price
- 4,590KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Report on grant of stock options
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.